RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Similar 12-Month BP Reductions with Renal Denervation and Sham Procedure
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 30
SP 21
OP 22
DO 10.1177/155989771430016
UL http://mdc.sagepub.com/content/14/30/21.abstract
AB The Renal Denervation in Patients With Uncontrolled Hypertension trial [SYMPLICITY HTN-3; NCT01418261] was the first randomized, blinded, sham-controlled clinical trial of renal denervation for treatment-resistant hypertension. In addition to the blinding and sham control, post hoc analyses have identified potential factors that may account for the negative results, including the patient population and procedural variability, which are discussed in this 12-month post hoc analysis.